Segui
Eileen Dawson
Eileen Dawson
Associate Director of Operations for the Quantum Systems Accelerator
Email verificata su lbl.gov
Titolo
Citata da
Citata da
Anno
Biomaterials for stem cell differentiation
E Dawson, G Mapili, K Erickson, S Taqvi, K Roy
Advanced drug delivery reviews 60 (2), 215-228, 2008
6032008
Recent advances in drug eluting stents
AS Puranik, ER Dawson, NA Peppas
International journal of pharmaceutics 441 (1-2), 665-679, 2013
1972013
Treatment of skeletal voids with implantable substrate hydrated with bone marrow concentrate
E Dawson, K Dunworth, T Sand, M Murphy, JB Rossman, M Samano, ...
US Patent 10,751,185, 2020
572020
Increased internal porosity and surface area of hydroxyapatite accelerates healing and compensates for low bone marrow mesenchymal stem cell concentrations in critically-sized …
ER Dawson, RK Suzuki, MA Samano, MB Murphy
Applied Sciences 8 (8), 1366, 2018
142018
Surface-Presentation of CpG and Protein–Antigen on Pathogen-Like Polymer Particles Generate Strong Prophylactic and Therapeutic Antitumor Protection
E Dawson, JA Leleux, P Pradhan, K Roy
ACS Biomaterials Science & Engineering 3 (2), 169-178, 2017
62017
Treatment of skeletal voids with implantable substrate hydrated with bone marrow concentrate
E Dawson, K Dunworth, T Sand, M Murphy, JB Rossman, M Samano, ...
US Patent 10,183,095, 2019
2019
Autologous Regenerative Therapies: Rapid Concentration of Progenitor Cells, Growth Factors, and Proteins at the Point-Of-Care
MB Murphy, ER Dawson, MA Samano, TT Sand
TISSUE ENGINEERING PART A 21, S235-S236, 2015
2015
Pathogen mimicking particles in an injectable synthetic-immune-priming center (sIPC) provide efficient immune cell activation and protection in murine tumor models
J Leleux, E Dawson, P Pradhan, I Sakamaki, H Qin, LW Kwak, K Roy
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–8